Tracheomalacia

2

Review clinical trials related to Tracheomalacia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Dynamic Airway CT is Diagnostic for Tracheomalacia in Children

The purpose of this pilot interventional study is to evaluate the use of Dynamic Airway Computed Tomography (DA-CT) for diagnosis of tracheomalacia in children 0-18 years for whom flexible bronchoscopy has been performed. The primary aims are to evaluate the diagnostic accuracy, image quality, and radiation exposure of DA-CT as a potential noninvasive alternative to the gold standard of flexible bronchoscopy in the diagnosis of tracheomalacia. The results from this pilot study will help to estimate sample size for a larger-scale study with more precise estimates of DA-CT diagnostic potential.

Participants needed: 25
Trial details
Age: 0-18Biological sex: AllType: InterventionalSponsor: NYU Langone HealthUpdated: Sep 26, 2024Locations: 2
Eligibility criteria

Participants 0-18 years old, with [+1]

Pregnancy or breastfeeding [+2]

Status: Not yet recruiting

Enhancing Lung Health in Kids With Structural Lung Damage and Malformations: Azithromycin (AZI) for Airway Infection Prevention

Children with lung and airway malformations or early structural lung damage face significant challenges, often leading to recurrent respiratory infections, hospitalizations, and decreased quality of life. Despite various interventions, effective strategies are urgently needed. The link between these conditions and persistent bacterial bronchitis remains unclear, possibly due to compromised airways and reduced mucociliary clearance. Although antibiotics can alleviate symptoms, relapse is common. Experts often prescribe prophylactic azithromycin, despite limited evidence of its benefits. Azithromycin shows promise due to its anti-inflammatory and immunomodulatory effects but lacks thorough evaluation in this population. To address this gap, we propose a double-blind, randomized controlled trial to assess azithromycin's effectiveness and safety in preventing respiratory infections in children with these conditions. This research aims to inform clinical practice and improve the health of affected children and their families.

Participants needed: 150
Trial details
Phase: Phase 3Age: 0-72Biological sex: AllType: InterventionalSponsor: Rigshospitalet, DenmarkUpdated: May 14, 2024
Eligibility criteria

CT and bronchoscopy verified and structural lung damage or congenital lung and a... [+3]

Asthmatic challenges: Patients without any of the conditions mentioned in table... [+7]